Related coverage linked through entity extraction aliases.
Jul 29, 2026
The Supreme Court allowed mifepristone to remain available via telehealth and mail while litigation continues. The FDA has also launched a six-month safety study of the abortion pill. Approximately 29% of U.S. abortions are now provided via telehealth.
Feb 18, 2026
Twenty-one state attorneys general and 60 members of Congress filed amicus briefs supporting Louisiana's lawsuit challenging the FDA's 2023 policy that removed in-person dispensing requirements for mifepristone, enabling mail-order distribution of abortion drugs.
Feb 18, 2026
59 Republican senators filed an amicus brief supporting Louisiana's lawsuit against the FDA, arguing the agency violated federal law by removing in-person dispensing requirements for mifepristone.
Feb 14, 2026
Sixty Republican members of Congress filed an amicus brief supporting Louisiana's lawsuit to restore in-person dispensing requirements for mifepristone, challenging Biden-era rules allowing mail-order abortion drugs.
